Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance

Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0062122. doi: 10.1128/aac.00621-22. Epub 2022 Jul 5.

Abstract

Pseudomonas aeruginosa is a major pathogen in burn wound infections. We present one of the first reports of small-colony variant (SCV) emergence of P. aeruginosa, taken from a patient under aminoglycosides for a persistent burn wound infection. We confirm the causative role of a single ispA mutation in SCV emergence and increased aminoglycoside resistance. IspA is involved in the synthesis of ubiquinone, providing a possible link between electron transport and SCV formation in P. aeruginosa.

Keywords: Pseudomonas aeruginosa; SCV; aminoglycosides; antibiotic resistance; burn wound infection; gentamicin; small-colony variant; tobramycin.

MeSH terms

  • Aminoglycosides* / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins* / genetics
  • Drug Resistance, Microbial
  • Humans
  • Mutation
  • Pseudomonas aeruginosa* / genetics

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Bacterial Proteins